Веб-аналітика
Launching our Private Beta in November 2025. Request an early access invitation.

PROMED.COM

Listed 13.11.2025
Trade Structure
Cash + Equity
Terms Flexibility
$ Cash Purchase Available
Target Sector
Healthtech

Owner's Valuation

Owner’s valuation may incorporate personal growth plans for the asset, previous offers turned down, proprietary insights, and current market or sector conditions.

$250 K - $500 K

Your Valuation - How to Value the Domain for Your Business

Learn how to accurately assess what this domain is worth to your specific business and industry. Our comprehensive guide helps you calculate ROI and make informed decisions.

Read the Complete Valuation Guide >

Description

Promed.com is a clear, authoritative name built around a prefix long associated with professionalism, advancement, and reliability in medical, health, and science-driven fields. The structure is simple to pronounce, easy to spell, and strong in recall, which improves marketing efficiency and supports long-term brand durability. As a .com, it delivers enterprise-level trust and global accessibility, positioning the name as a credible foundation for organizations operating in regulated or high-stakes environments.

Its semantic alignment makes Promed.com a natural fit for companies in healthcare delivery, medical devices, telemedicine, diagnostics, biotech, and digital health platforms. The name conveys purpose and competence without restricting the brand to a single specialty. It can anchor a provider network, a next-generation virtual care system, a laboratory platform, a clinical AI solution, or a medical device portfolio. Because the term “pro” suggests advancement and the term “med” signals medical focus, the brand narrative is instantly understood by professionals, partners, and patients.

Beyond clinical use cases, Promed.com adapts well to enterprise and B2B environments. It can support healthcare infrastructure software, supply chain management, payer solutions, workforce systems, training programs, or regulatory technology. Its clarity shortens sales cycles by communicating professionalism and medical relevance without requiring further explanation. For organizations developing ecosystem-wide tools, the name provides a stable anchor that can support multiple product lines and future expansion.

Promed.com is also suitable for consumer-facing concepts where trust and ease of understanding drive adoption. It can house wellness services, consumer diagnostics, devices, subscription programs, or content platforms centered on health literacy and proactive care. The term is globally familiar and culturally neutral, which reduces friction around international rollout and localization.

The domain supports strong brand architecture. Promed.com can sit above clinical modules, patient engagement tools, enterprise dashboards, research initiatives, and regional divisions while maintaining a coherent identity. Its balanced structure works across a wide range of visual languages, from highly technical interfaces to consumer-friendly design systems.

Operationally, Promed.com integrates cleanly across email, patient communication, investor materials, partner documentation, and enterprise systems. Its clarity enhances trust in procurement cycles and regulatory-facing environments. For organizations aiming to scale across sectors shaped by innovation, compliance, and patient outcomes, it offers a durable foundation capable of expanding with the business.

Opportunity Map:

* Launch a flagship clinical or digital health platform under a credible, medically aligned identity
* Consolidate products, tools, and regional operations within a unified brand architecture
* Strengthen international expansion with a name that reads clearly across languages and markets
* Improve marketing efficiency through strong first-impression clarity and broad familiarity
* Support enterprise sales, partnerships, and investor communication with a trustworthy, future-ready domain

If strategic ownership of Promed.com aligns with your roadmap, request details to explore fit.

Trade Details

Preferred Structure

Cash + Equity

Minimum Company Valuation

Not specified

Valuation Status

Pre-Seed Seed Series A Series B Growth Established

Target Sectors

healthtech biotech

Flexibility

Cash Purchase Available




Contact Company

Send a message to the owner of Company Name

Your Credits
0 credits
Contact Price
credits
Describe your interest, proposal, or questions... 0/1000 characters

Your message will be delivered securely to the broker owner. Credits are only deducted upon successful delivery.